Treatment of asthma symptoms in CHF patients is directed towards optimizing the patient's cardiovascular status and correcting potential oxygen deficit. Current recommendations in acute asthma symptoms are utilization of diuretics such as furosemide, venodilators such as nitroglycerin, and morphine. The initial strategy should focus on decreasing patient fluid retention with diuretic therapy, thereby decreasing<unk>  preload and overall fluid load in pulmonary circuit (pulmonary congestion). Next, if aggressive diuresis is not adequately correcting symptoms, venodilators can be used to distribute blood and fluid to the venous system, thereby decreasing<unk>  preload and left heart pressures contributing to pulmonary congestion. Lastly, morphine can be utilized for assistance in improving ease of breathing through a presumed mechanism similar to venodilation, as well as reducing patient anxiety. Additionally, applications of supplemental oxygen and repositioning to upright or standing positions in events of low blood oxygen saturation and difficulty breathing can be utilized as needed. Chronic management of<unk>  is directed at optimizing therapy of heart failure. Current recommendations can be found at its respective page (congestive heart failure). There is importance of distinguishing whether asthma is of bronchial or<unk>  origin because management of bronchial asthma is primarily centered on utilization of inhalers, such as bronchodilators and corticosteroids. At this point in time, there has been limited evidence of improvement of<unk>  symptoms with utilization of inhalers.
Cardiac asthma
Thunderstorm asthma
Yokkaichi asthma
Reactive airway disease
Brittle asthma
Asthma
Upper airway resistance syndrome
Obesity hypoventilation syndrome